SMTL ID : 1t4f.1

Structure of human MDM2 in complex with an optimized p53 peptide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x ARG- PHE- MET- ASP- TYR- TRP- GLU- GLY- LEU: optimized p53 peptide(Non-covalent)

ARG-PHE-MET-ASP-TYR-TRP-GLU-GLY-LEU.1: 14 residues within 4Å: Chain A: L.39, L.42, G.43, Q.44, I.46, M.47, Y.52, Q.57, H.58, V.60, V.78, H.81, I.84, Y.85 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:L.42, A:L.42, A:I.46, A:I.46, A:Y.52, A:H.58, A:V.60, A:V.78, A:I.84 Hydrogen bonds: A:G.43, A:Q.57 Water bridges: A:Q.44, A:Q.57, A:K.79 pi-Stacking: A:H.58

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 2 residues within 4Å: Chain A: E.8, Q.9 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:E.8, A:Q.9

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Grasberger, B.L. et al., Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells. J.Med.Chem. (2005)

Release Date

2005-02-08

Peptides

Ubiquitin-protein ligase E3 Mdm2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
M

Ubiquitin-protein ligase E3 Mdm2

Related Entries With Identical Sequence